Eppin Pharma News Today

The road to the commercial contraceptive market is a “constant battle,” admits Michael O’Rand, Ph.D. For nearly a decade, O’Rand’s company Eppin Pharma Inc. has been traveling the long and expensive path of developing a drug that has the potential to completely transform family planning: a male birth control pill. “It costs hundreds of millions of dollars

Durham pharmaceutical company Eppin Pharma has secured an investment of up to $800,000 from the Male Contraceptive Initiative, a national nonprofit also based in Durham, to help initiate clinical trials for its male birth-control pill.

Researchers aim to usher in a new vision of what feminist bioethicist Lisa Campo-Engelstein has called “contraceptive justice.”